Salud financiera de hoja de balance de Medexus Pharmaceuticals
Salud financiera controles de criterios 3/6
Medexus Pharmaceuticals tiene un patrimonio de accionistas total de $32.7M y una deuda total de $42.5M, lo que sitúa su ratio deuda-patrimonio en 129.8%. Sus activos y pasivos totales son $145.4M y $112.6M respectivamente. El BAIT de Medexus Pharmaceuticals es de $12.8M, por lo que su ratio de cobertura de intereses es de 1.4. Tiene efectivo e inversiones a corto plazo que ascienden a $7.0M.
Información clave
129.8%
Ratio deuda-patrimonio
US$42.50m
Deuda
| Ratio de cobertura de intereses | 1.4x |
| Efectivo | US$6.97m |
| Patrimonio | US$32.74m |
| Total pasivo | US$112.63m |
| Activos totales | US$145.37m |
Actualizaciones recientes sobre salud financiera
Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?
Nov 05
Here's Why Medexus Pharmaceuticals (TSE:MDP) Has A Meaningful Debt Burden
Apr 25Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?
Sep 11Medexus Pharmaceuticals (TSE:MDP) Use Of Debt Could Be Considered Risky
Jan 19Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?
Sep 22Is Medexus Pharmaceuticals (TSE:MDP) Weighed On By Its Debt Load?
Dec 16Recent updates
Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?
Nov 05There May Be Reason For Hope In Medexus Pharmaceuticals' (TSE:MDP) Disappointing Earnings
Aug 19Medexus Pharmaceuticals Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Aug 10Medexus Pharmaceuticals Inc. (TSE:MDP) Shares Fly 29% But Investors Aren't Buying For Growth
Jul 31The Market Doesn't Like What It Sees From Medexus Pharmaceuticals Inc.'s (TSE:MDP) Revenues Yet
Jun 15Here's Why Medexus Pharmaceuticals (TSE:MDP) Has A Meaningful Debt Burden
Apr 25Revenues Working Against Medexus Pharmaceuticals Inc.'s (TSE:MDP) Share Price Following 26% Dive
Mar 03Medexus Pharmaceuticals Inc.'s (TSE:MDP) Shares Leap 89% Yet They're Still Not Telling The Full Story
Jan 06Here's Why Medexus Pharmaceuticals (TSE:MDP) Has Caught The Eye Of Investors
Oct 11Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?
Sep 11Medexus Pharmaceuticals (TSE:MDP) Use Of Debt Could Be Considered Risky
Jan 19Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?
Sep 22Is Medexus Pharmaceuticals (TSE:MDP) Weighed On By Its Debt Load?
Dec 16Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($64.2M) de MDP superan a sus pasivos a corto plazo ($63.4M).
Pasivo a largo plazo: Los activos a corto plazo de MDP ($64.2M) superan a sus pasivos a largo plazo ($49.2M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: La relación deuda neta-capital de MDP (108.5%) se considera alta.
Reducción de la deuda: El ratio deuda-patrimonio de MDP ha crecido de 70.4% a 129.8% en los últimos 5 años.
Cobertura de la deuda: La deuda de MDP está bien cubierta por el flujo de caja operativo (52.2%).
Cobertura de intereses: Los pagos de intereses de la deuda de MDP no están bien cubiertos por el BAIT (1.4x cobertura).